1 Falabella R.Surgical treatment of vitiligo: why,when and how.J Eur Acad Dermatol Venereol,2003,17: 518-520. 2 全国中西医结合皮肤性病学会色素病学组.白癜风临床分型及疗效标准(草案).中华皮肤科杂志,1995,28: 212. 3 Blomhoff A,Kemp EH,Gawkrodger DJ,et al.CTLA4 polymorphisms are associated with vitiligo,in patients with concomitant autoimmune diseases.Pigment Cell Res,2005,18: 55-58. 4 Van Geel N,Ongenae K,Naeyaert JM.Surgical techniques for vitiligo: a review.Dermatology,2001,202: 162-166. 5 谭雪晶,涂彩霞,程艳杰,等.白癜风患者血清及负压吸引疱疱液一氧化氮及相关细胞因子检测.中华皮肤科杂志,2003,36:400-402. 6 涂彩霞,傅红文,林熙然.白癜风患者血清及皮肤组织液可溶性白介素 2 受体的检测.中华皮肤科杂志,1997,30: 224-226. 7 Hwang JH,Ahn JS,Kim SD,et al.The changes of serum soluble intercellular adhesion molecule-1 after systemic steroid treatment in vitiligo.J Dermatol Sci,1999,22: 11-16. 8 Vestergaard C,Gesser B,Lohse N,et al.Monocyte chemotactic and activating factor (MCAF/MCP-1) has an autoinductive effect in monocytes,a process regulated by IL-10.J Dermatol Sci,1997,15:14-22. |